semaglutide and high cholesterol Ozempic for Cholesterol: Evidence NHS Treatment Options Obesity: Disease or surrogate marker?

Whilst psychological therapies remain the recommended first-line treatment in the UK, emerging research suggests that GLP-1 receptor agonistsmedications originally developed for type 2 diabetes and weight managementmay influence eating behaviours beyond simple appetite suppression

The GLP-1 receptor activation slows gastric emptying, reduces appetite through hypothalamic signaling, and enhances insulin secretion in a glucose-dependent manner

Gao X, Hua X, Wang X, et al

Bouthors, C., Benzakour, A

4:45-5:00 PM ET Obesity Non-Product Association Between Body Mass Index and Surgeries for Knee and Hip Joint Replacements